Dose escalation of Xeloda [capecitabine] or 5FU [fluorouracil] continuous infusion in combination with Taxotere [docetaxel] and concurrent once weekly, hypofractionated chest radiotherapy for advanced non small cell lung cancer: a phase I/II study.
Withdrawn prior to enrolment
Phase of Trial: Phase I/II
Latest Information Update: 24 Mar 2009
At a glance
- Drugs Capecitabine (Primary) ; Docetaxel (Primary) ; Fluorouracil (Primary)
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- 24 Mar 2009 Additional lead trial centre and investigator identified as reported by ClinicalTrials.gov.
- 27 Feb 2006 New trial record.